Platform Technology Partners Has $1.18 Million Stake in The Clorox Company (NYSE:CLX)

Platform Technology Partners increased its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 3.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,230 shares of the company’s stock after acquiring an additional 238 shares during the period. Platform Technology Partners’ holdings in Clorox were worth $1,178,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Innealta Capital LLC acquired a new position in Clorox in the second quarter worth $30,000. Trifecta Capital Advisors LLC raised its holdings in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares during the last quarter. First Foundation Advisors acquired a new position in Clorox during the 1st quarter worth about $31,000. Family Firm Inc. bought a new stake in Clorox during the 2nd quarter worth about $31,000. Finally, Quarry LP increased its position in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their price target for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Evercore ISI decreased their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Barclays boosted their target price on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research report on Friday, November 1st. Deutsche Bank Aktiengesellschaft raised their price target on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, Citigroup lifted their price objective on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Five analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, Clorox has an average rating of “Hold” and a consensus target price of $155.00.

Get Our Latest Stock Report on Clorox

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.57% of the stock is owned by insiders.

Clorox Stock Down 0.1 %

Shares of NYSE CLX opened at $165.05 on Tuesday. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $169.09. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The stock has a market cap of $20.43 billion, a P/E ratio of 57.51, a P/E/G ratio of 3.05 and a beta of 0.41. The firm has a 50 day moving average price of $162.28 and a 200 day moving average price of $146.95.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm’s revenue was up 27.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.49 EPS. Analysts expect that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.96%. The ex-dividend date was Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.